SCHEMBL3759838

SCHEMBL3759838

CC1(C)CC(=O)c2sc(N3CCOCC3)c(-c3cccc4c3oc3ccccc34)c2C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 16/20 0.48
PIK3CD O00329 7/20 0.48
PIK3CB P42338 7/20 0.48
ATM Q13315 1/20 0.47
BRD4 O60885 3/20 0.43
PIK3CA P42336 4/20 0.39
PIK3CG P48736 4/20 0.39
BRDT Q58F21 3/20 0.37
MTOR P42345 2/20 0.37
KCNH2 Q12809 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
PDE2A O00408 1/20 0.37
PIK3C2A O00443 1/20 0.37
PIK3R2 O00459 1/20 0.37
PIK3C2B O00750 1/20 0.37
PDE5A O76074 1/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3760389 0.85 BRD4 (0.46) PRKDCPIK3CDPIK3CBBRD4PIK3CA
SCHEMBL3766018 0.82 PRKDC (0.49) PRKDCPIK3CDPIK3CBBRD4PIK3CA
SCHEMBL3759992 0.81 BRD4 (0.47) PRKDCPIK3CDPIK3CBBRD4PIK3CA
SCHEMBL3765024 0.78 BRD4 (0.49) PRKDCPIK3CDPIK3CBBRD4PIK3CA
SCHEMBL3754887 0.78 PRKDC (0.47) PRKDCPIK3CDPIK3CBATMBRD4
SCHEMBL3756426 0.77 PIK3CD (0.44) PRKDCPIK3CDPIK3CBBRD4PIK3CA
SCHEMBL3758948 0.77 PIK3CD (0.42) PRKDCPIK3CDPIK3CBBRD4PIK3CA
SCHEMBL3759255 0.76 BRD4 (0.52) PRKDCPIK3CDPIK3CBATMBRD4
SCHEMBL3764802 0.75 BRD4 (0.39) PRKDCPIK3CDPIK3CBBRD4PIK3CA
SCHEMBL3757704 0.75 PIK3CD (0.42) PRKDCPIK3CDPIK3CBBRD4PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PRKDC 112/4885PIK3CD 9/4885PIK3CB 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.